• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Nursing Staffing Platform Intelycare Scores $45M in Funding, Debt Financing

Share:

February 24, 2020

This morning workforce management system IntelyCare raked in $45 million in its Series B funding round. The total funding number was made up of equity and debt financing. Endeavour Vision led the round with participation from Kaiser Permanente Ventures and Generator Ventures.

WHAT THEY DO

The company focuses on matching nurses and certified nursing assistants with acute healthcare facilities for certain shifts.

Nurses and CNAs can use the company’s app to look through available shifts in their geographical area. The service will ask the clinicians about their preferences, needs and abilities in order to display the most relevant opportunities.

IntelyCare then uses artificial intelligence to look at the clinician’s preferences and the healthcare system’s needs in order to put the best potential matches together. The company uses predictive analytics to help figure out a match.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The app also includes interactive training activities for clinicians, including videos and quizzes.

WHAT IT’S FOR

The company said it plans to use the new money to continue to build its gig economy platform and data science tech.

“With rising rates of chronic conditions and an aging population, there is a critical need for new technologies to support the post-acute care workforce,” Sam Brasch, senior managing director and vice president, Kaiser Permanente Ventures, said in a statement. “IntelyCare’s approach augments available nurses to help overcome these complex challenges, reduce burnout and attrition, and drive greater patient care.”

MARKET SNAPSHOT

Staffing has been a pain point for hospital organization for quite some time. However, there are numerous startup looking to tackle this issue. In 2017 freelance clinical work platform Nomad expanded the service to nurses, in addition to doctors.

Another in the space is Bay Area startup Trusted Health whose platform helps nurses find jobs and negotiate pay, as well as manage credentialing and paperwork and nurse.

ON THE RECORD

“As an investor in innovative medical and digital health technologies, we look for companies with disruptive solutions to the challenges facing today’s healthcare system,” Rob Barmann, senior investment director, Endeavour Vision. “IntelyCare’s rapid and significant growth demonstrates the value it is bringing to the nursing sector. With a unique technology and an experienced team, the company is well-positioned to develop further, and we are proud to support it in its next phase of growth.”

Source: MobiHealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cognoa And EVERSANA™ Announce Partnership To Advance The Commercialization Standard For Prescription Digital MedicinesCognoa And EVERSANA™ Announce Partnership To Advance The Commercialization Standard For Prescription Digital Medicines
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business UnitNoramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • ALSA Ventures Closes US$59 Million European Biotech Venture Capital FundALSA Ventures Closes US$59 Million European Biotech Venture Capital Fund
  • PicnicHealth, Roche Partner to Accelerate Neurological Disease ResearchPicnicHealth, Roche Partner to Accelerate Neurological Disease Research
  • Sarepta to buy gene therapy developer Myonexus for $165 mlnSarepta to buy gene therapy developer Myonexus for $165 mln
  • Danaher to acquire Abcam for $24.00 per ShareDanaher to acquire Abcam for $24.00 per Share
  • Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Recruitment of Les Funtleyder as DirectorTenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Recruitment of Les Funtleyder as Director
  • FDA Approves First Ortho-K Contact Lens to Manage MyopiaFDA Approves First Ortho-K Contact Lens to Manage Myopia

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications